• 81 Hits
  • Search Condition : Filter (MeSH = Osteoclasts / drug effects*)
Species Resource Title
Human and Animal Cells 10T1/2(RCB0247) Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Human and Animal Cells RAW 264(RCB0535) Irijimasides A-E, Macrolide Glycosides from an Okeania sp. Marine Cyanobacterium.
Human and Animal Cells ST2(RCB0224) Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-β1 via the ubiquitin-proteasome system.
Human and Animal Cells Saos-2(RCB0428) , ST2(RCB0224) In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells.
Human and Animal Cells RAW 264(RCB0535) Honokiol inhibits osteoclast differentiation and function in vitro.
Human and Animal Cells RAW 264(RCB0535) Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Human and Animal Cells MC3T3-E1(RCB1126) Calcium hydroxide suppresses Porphyromonas endodontalis lipopolysaccharide-induced bone destruction.
Human and Animal Cells RAW 264(RCB0535) Shark protein improves bone mineral density in ovariectomized rats and inhibits osteoclast differentiation.
Human and Animal Cells RAW 264(RCB0535) F-spondin inhibits differentiation of clastic precursors via lipoprotein receptor-related protein 8 (LRP8).
Human and Animal Cells MC3T3-E1(RCB1126) Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway.
Human and Animal Cells MG-63(RCB1890) Thymus-expressed chemokine enhances Porphyromonas gingivalis LPS-induced osteoclast formation via NFATc1 activation.
Human and Animal Cells MC3T3-E1(RCB1126) Osteoprotective Effects of Loganic Acid on Osteoblastic and Osteoclastic Cells and Osteoporosis-Induced Mice.
Human and Animal Cells RAW 264(RCB0535) Osteoclast Differentiation Is Suppressed by Increased O-GlcNAcylation Due to Thiamet G Treatment.
Human and Animal Cells RAW 264(RCB0535) Fluorinated Kavalactone Inhibited RANKL-Induced Osteoclast Differentiation of RAW264 Cells.
Human and Animal Cells ST2(RCB0224) Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Human and Animal Cells RAW 264(RCB0535) Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
Human and Animal Cells ST2(RCB0224) Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Human and Animal Cells MC3T3-E1(RCB1126) Anti-Osteoporotic Effects of Kukoamine B Isolated from Lycii Radicis Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice.
Medaka osterix-DsRed/TRAP-GFP (TG1359) Treatment with synthetic glucocorticoid impairs bone metabolism, as revealed by in vivo imaging of osteoblasts and osteoclasts in medaka fish.
Human and Animal Cells RAW 264(RCB0535) Identification and structure-activity relationship (SAR) of chemical constituents from Daemonorops draco (Willd.) Blume and selected commercial flavonoids on anti-osteoclastogenesis activity.